BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30643389)

  • 1. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
    Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
    Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity.
    Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y
    Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
    Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
    Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis.
    Kim W; Kim D; Jeong S; Ju S; Lee H; Kim S; Yoo JW; Yoon IS; Jung Y
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31703411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent.
    Lee H; Park S; Ju S; Kim S; Yoo JW; Yoon IS; Min DS; Jung Y
    Mol Pharm; 2021 Apr; 18(4):1730-1741. PubMed ID: 33661643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
    Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
    J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach.
    Suneela D; Gaurav V; Himanshu R
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):328-40. PubMed ID: 24001333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug.
    Park H; Kim W; Kim D; Jeong S; Jung Y
    Curr Mol Pharmacol; 2019; 12(4):272-280. PubMed ID: 30848228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
    Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.
    Gálvez J; Garrido M; Rodríguez-Cabezas ME; Ramis I; de Medina FS; Merlos M; Zarzuelo A
    Inflamm Bowel Dis; 2003 Nov; 9(6):363-71. PubMed ID: 14671485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis.
    Kim H; Huh J; Jeon H; Choi D; Han J; Kim Y; Jung Y
    J Pharm Sci; 2009 Jan; 98(1):159-68. PubMed ID: 18399548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone Azo-Linked with Two Mesalazine Moieties Is a "Me-Better" Alternative to Sulfasalazine.
    Kang C; Kim J; Ju S; Park S; Yoo JW; Yoon IS; Kim MS; Jung Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
    J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.